Skip to main content

KURE - KraneShares MSCI All China Health Care Index ETF


KURE - KraneShares MSCI All China Hlth Care ETF

KURE holds all types of publicly-issued shares (including A-shares, B-shares, H-shares, N-shares, P-chips, and Red chips) of large- and midcap Chinese companies in the healthcare sector. Stocks must meet minimum trading and liquidity requirements and be classified in the healthcare sector under MSCI’s GICS standard. Holdings are market-cap-weighted with an adjustment based on the proportion of shares available to foreign investors—except for A-shares, which are treated as 100% available. Weights are also modified using a 10/40 capping methodology. Overall, KURE provides exposure to a relatively small slice of the Chinese economy. The index is rebalanced quarterly.


China is one of the fastest growing major healthcare markets in the world with a ten-year compound annual growth rate of 13%, compared to just 3% in the United States and 2% in Japan1. China is the second largest healthcare market globally with total healthcare expenditures reaching $1.1 trillion in 2019, increasing at an average annual growth rate of 11% over the last 5 years2. There is still opportunity for considerable growth in China’s healthcare market with per capita health spending at just $501, compared to an average of over $5,700 for the world’s top eight healthcare markets3. China’s aging population, rising incomes and increasing urbanization may provide a sustained catalyst for growth in China’s healthcare sector.